[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334066-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334066-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","efficient-pegylated-magnetic-nanoniosomes-for-co-delivery-of-artemisinin-and-metformin-a-new-frontier-in-chemotherapeutic-efficacy-and-cancer-therapy","Efficient PEGylated magnetic nanoniosomes for co-delivery of artemisinin and metformin - a new frontier in chemotherapeutic efficacy and cancer therapy","","PEGylated magnetic nanoniosomes (PMNios) were developed as a platform for co-delivering artemisinin (ART) and metformin (MET) in cancer therapy. The system combined PEG surface modification to enhance bioavailability with Fe3O4 magnetic nanoparticles to enable magnet-assisted targeted delivery. PMNios were characterized by zeta potential, size, morphology, and entrapment efficiency, reaching 88% drug loading, ~298 nm average size, PDI 0.32, and zeta potential around −19 mV stability. Compared with empty, non-magnetic, and non-PEGylated controls, PMNios showed spherical morphology, improved stability, and controlled release. In vitro testing against A549 cells under an external magnetic field demonstrated effective toxicity, reduced Bcl2 and increased Bax expression, and strong cellular internalization via endocytosis, supporting improved therapeutic index with minimized side effects.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/efficient-pegylated-magnetic-nanoniosomes-for-co-delivery-of-artemisinin-and-metformin-a-new-frontier-in-chemotherapeutic-efficacy-and-cancer-therapy/334066/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/efficient-pegylated-magnetic-nanoniosomes-for-co-delivery-of-artemisinin-and-metformin-a-new-frontier-in-chemotherapeutic-efficacy-and-cancer-therapy/334066.png","ImageObject",300,407,{"name":42,"@type":43},"Skyler","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How are PEGylated magnetic nanoniosomes constructed for ART and MET co-delivery?","Question",{"text":63,"@type":64},"The nano-niosome surface is modified by PEGylation, and the core is equipped with Fe3O4 magnetic nanoparticles. Drugs are then loaded into the resulting PEGylated magnetic nanoniosomes (PMNios).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What characterization results support the stability and formulation quality of PMNios?",{"text":68,"@type":64},"PMNios were evaluated by zeta potential, size, morphology, and entrapment efficiency. Reported values include 88% drug loading, ~298 nm average size, PDI 0.32, and zeta potential of about −19 mV, indicating stability.",{"name":70,"@type":61,"acceptedAnswer":71},"What in vitro findings were observed for PMNios-ART-MET against A549 cells under an external magnetic field?",{"text":72,"@type":64},"PMNios-ART-MET showed appropriate toxicity in the presence of an external magnetic field, lower Bcl2 expression, higher Bax expression, and well internalization into A549 cells with predominant endocytosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334066,1790631289,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":4},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nEfficient PEGylated magnetic nanoniosomes for co-delivery of artemisinin and metformin: anew frontier in chemotherapeutic efficacy and cancer therapy  \nRasoul Shahbazi1, Zohreh Mirjafary1􀀍, Nosratollah Zarghami2􀀍 & Hamid Saeidian3  \nTwo strategies were employed to modify the performance of the nano-niosome drug delivery system. Initially, the surface of the nano-niosomes underwent modification through the inclusion of polyethylene glycol, thereby altering its properties. Additionally, the core of the nano-niosomes was equipped with Fe3O4 magnetic nanoparticles to impart magnetic characteristics to the system. This study presents the development of PEGylated magnetic nanoniosomes (PMNios) forthe co-delivery of artemisinin (ART) and metformin (MET) in cancer therapy, highlighting significant advancementsin chemotherapeutic efficacy. The magnetization of the nano-niosomes facilitated the targeted delivery of drugs to specific tissues, while PEGylation improved the bioavailability of the nanoniosomes. These PEGylated magnetic niosomes (PMNios) were then loaded with artemisinin and metformin drugs. The synthesized PMNios were thoroughly evaluated in terms of zeta potential, size, morphology, and entrapment efficiency. The PMNios achieved a drug loading efficiency of 88% . They exhibited an average size of 298 nm, a polydispersity index of 0.32, and a zeta potential of − 19 mV, indicating the complete stability. SEM and TEM images of the PMNios revealed a spherical morphology. Subsequently, the PMNios were compared with other forms of nano-niosomes, including empty niosomes, non-magnetic niosomes, and non-PEGylated niosomes. The encapsulation of the nano-niosomes with magnetic nanoparticles allows for faster delivery of the encapsulated drugs to the tumor site, while PEGylation improved the stability, bioavailability, and controlled release of  \nthe PMNios. Furthermore, the in-vitro effectiveness of various formulations of the PMNios against A549, a lung cancer cell line, demonstrated that the PMNios exhibited appropriate toxicity towards cancer cell lines in the presence of an external magnetic field. Gene expression level of Bcl2 were lower forthe PMNios-ART-MET system, whereas the level of Bax were higher than the other group. The PMNios-ART-MET system also demonstrated well internalization into theA549 cells and preponderant endocytosis. These findings underscore the novelty and potential of PMNios as a robust platform for the targeted co-delivery of hydrophilic and hydrophobic drugs, promising a new frontier in cancer therapy by enhancing the therapeutic index and minimizing side effects.  \nKeywords Magnetic noisome, Metformin, Artemisinin, Lung cancer, Targeted drug delivery system  \nNiosomes have emerged as innovative drug delivery systems composed of nonionic surfactant vesicles, offering exceptional properties for delivering both hydrophilic and hydrophobic drugs1,2. These nano-carriers have gained popularity due to their uniform and straightforward synthesis, extended shelf-life, cost-effectiveness, biocompatibility, chemical and physical stability, and low toxicity. Nano-niosomes have found applications in various fields such as cancer therapy, skin care treatments, gene delivery, drug targeting, and anti-neoplastic treatment. One notable application of niosomes is their use in targeted co-delivery of multiple drugs to specific tissues3,4. Among the different methods developed for targeting cancerous tissues, magnetic drug delivery  \n1Department of Chemistry, Science and Research Branch, Islamic Azad University, Tehran, Iran. 2Department of Medical Biotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Sciences, Tabriz, Iran. 3Department of Science, Payame Noor University (PNU), P.O. Box 19395-3697, Tehran, Iran. 􀀍 email: [zmirjafary@srbiau.ac.ir](zmirjafary@srbiau.ac.ir); [zarghami@tbzmed.ac.ir](zarghami@tbzmed.ac.ir","cbCain1vubKxp6q8","https://ap.wps.com/l/cbCain1vubKxp6q8","pdf",4010305,16,"English","# Abstract\n## Formulation design\n## Characterization and stability\n## Comparative evaluation\n## In vitro anticancer effects","[{\"question\":\"How are PEGylated magnetic nanoniosomes constructed for ART and MET co-delivery?\",\"answer\":\"The nano-niosome surface is modified by PEGylation, and the core is equipped with Fe3O4 magnetic nanoparticles. Drugs are then loaded into the resulting PEGylated magnetic nanoniosomes (PMNios).\"},{\"question\":\"What characterization results support the stability and formulation quality of PMNios?\",\"answer\":\"PMNios were evaluated by zeta potential, size, morphology, and entrapment efficiency. Reported values include 88% drug loading, ~298 nm average size, PDI 0.32, and zeta potential of about −19 mV, indicating stability.\"},{\"question\":\"What in vitro findings were observed for PMNios-ART-MET against A549 cells under an external magnetic field?\",\"answer\":\"PMNios-ART-MET showed appropriate toxicity in the presence of an external magnetic field, lower Bcl2 expression, higher Bax expression, and well internalization into A549 cells with predominant endocytosis.\"}]","Efficient PEGylated magnetic nanoniosomes for co-delivery of artemisinin and metformin - a new frontier in chemotherapeutic efficacy and cancer therapy | PDF",1790005184]